BioCryst Pharmaceuticals Inc (BCRX):企業の財務・戦略的SWOT分析

◆英語タイトル:BioCryst Pharmaceuticals Inc (BCRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH66540FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

BioCryst Pharmaceuticals Inc (BCRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioCryst Pharmaceuticals Inc (BioCryst) designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary Angioedemaon. It integrates disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through the process known as structure-guided drug design. BioCryst’s products include peramivir injections, which consists of Rapivab, Alpivab, Rapiacta and Peramiflu for the treatment of Influenza. The company has strategic partnerships with corporate and academic institutes and has research operations in Birmingham, Alabama. BioCryst is headquartered in Durham, North Carolina, the US.

BioCryst Pharmaceuticals Inc Key Recent Developments

Feb 25,2021: BioCryst reports fourth quarter and full year 2020 financial results and upcoming key milestones
Feb 11,2021: BioCryst to Report Fourth Quarter and Full Year 2020 Financial Results on February 25
Nov 13,2020: BioCryst presents new data highlighting burden of therapy with current injectable prophylaxis medication for HAE
Aug 06,2020: BioCryst reports second quarter 2020 financial results and upcoming key milestones
Jun 06,2020: Hereditary angioedema patients report breakthrough attacks on current injectable/infused prophylaxis medication

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
BioCryst Pharmaceuticals Inc – Key Facts
BioCryst Pharmaceuticals Inc – Key Employees
BioCryst Pharmaceuticals Inc – Key Employee Biographies
BioCryst Pharmaceuticals Inc – Major Products and Services
BioCryst Pharmaceuticals Inc – History
BioCryst Pharmaceuticals Inc – Company Statement
BioCryst Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioCryst Pharmaceuticals Inc – Business Description
BioCryst Pharmaceuticals Inc – Corporate Strategy
BioCryst Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
BioCryst Pharmaceuticals Inc – Strengths
BioCryst Pharmaceuticals Inc – Weaknesses
BioCryst Pharmaceuticals Inc – Opportunities
BioCryst Pharmaceuticals Inc – Threats
BioCryst Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioCryst Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 25, 2021: BioCryst reports fourth quarter and full year 2020 financial results and upcoming key milestones
Feb 11, 2021: BioCryst to Report Fourth Quarter and Full Year 2020 Financial Results on February 25
Nov 13, 2020: BioCryst presents new data highlighting burden of therapy with current injectable prophylaxis medication for HAE
Aug 06, 2020: BioCryst reports second quarter 2020 financial results and upcoming key milestones
Jun 06, 2020: Hereditary angioedema patients report breakthrough attacks on current injectable/infused prophylaxis medication
May 15, 2020: BioCryst celebrates HAE patients with HAE Global Walk
May 06, 2020: BioCryst reports first quarter 2020 financial results and upcoming key milestones
Apr 02, 2020: BioCryst appoints Anthony Doyle Chief Financial Officer
Mar 05, 2020: BioCryst reports fourth quarter and full year 2019 financial results and upcoming key milestones
Feb 25, 2020: BioCryst appoints Alan G. Levin to Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
BioCryst Pharmaceuticals Inc, Key Facts
BioCryst Pharmaceuticals Inc, Key Employees
BioCryst Pharmaceuticals Inc, Key Employee Biographies
BioCryst Pharmaceuticals Inc, Major Products and Services
BioCryst Pharmaceuticals Inc, History
BioCryst Pharmaceuticals Inc, Other Locations
BioCryst Pharmaceuticals Inc, Subsidiaries
BioCryst Pharmaceuticals Inc, Key Competitors
BioCryst Pharmaceuticals Inc, Ratios based on current share price
BioCryst Pharmaceuticals Inc, Annual Ratios
BioCryst Pharmaceuticals Inc, Annual Ratios (Cont...1)
BioCryst Pharmaceuticals Inc, Interim Ratios
BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioCryst Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[BioCryst Pharmaceuticals Inc (BCRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emgesa SA ESP:企業の戦略的SWOT分析
    Emgesa SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Antero Resources Corporation (AR)-石油・ガス分野:企業M&A・提携分析
    Summary Antero Resources Corporation (Antero), formerly Antero Resources Appalachian Corporation, is an independent oil and natural gas company that carries out exploration, development, production and acquisition of natural gas, natural gas liquids (NGLs) and oil properties in the Appalachia Basin. …
  • Keihan Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Keihan Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Keihan Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Endo International Plc (ENDP):企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • P2P Global Investments PLC (P2P):企業の財務・戦略的SWOT分析
    P2P Global Investments PLC (P2P) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • ProMIS Neurosciences Inc (PMN):企業の財務・戦略的SWOT分析
    ProMIS Neurosciences Inc (PMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • BioMotiv LLC:医療機器:M&Aディール及び事業提携情報
    Summary BioMotiv LLC (BioMotiv) is a therapeutics licensing and development service provider. The company offers therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. It portfolio includes psoriasis, inflammatory bowel diseases, cancer, retinitis pi …
  • OMV Petrom SA (SNP):電力:M&Aディール及び事業提携情報
    Summary OMV Petrom SA (Petrom), a subsidiary of OMV AG, is an integrated energy company that explores for, develops and produces crude oil and natural gas. The company processes and refines crude oil and sells refined products. It conducts power generation and has considerable wind energy operations …
  • Chugach Electric Association, Inc.:企業の発電所・SWOT分析2018
    Chugach Electric Association, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • Support.com, Inc. (SPRT):企業の財務・戦略的SWOT分析
    Support.com, Inc. (SPRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Enerjisa Enerji Uretim AS:発電所・企業SWOT分析
    Enerjisa Enerji Uretim AS - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Bioanalytical Systems, Inc.:企業の戦略・SWOT・財務情報
    Bioanalytical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bioanalytical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Powerex Inc:企業の戦略的SWOT分析
    Powerex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tuas Power Ltd:企業の戦略的SWOT分析
    Tuas Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • The Hong Kong and China Gas Co Ltd (3):石油・ガス:M&Aディール及び事業提携情報
    Summary The Hong Kong and China Gas Company Limited (Towngas) is an energy company that produces distributes and markets the gas, water and related activities in Hong Kong and China. The company also carries out the LPG filling stations and utilization of landfill gas. The company has interests in v …
  • VisionQuest Biomedical LLC:企業の製品パイプライン分析2018
    Summary VisionQuest Biomedical LLC (VisionQuest) is a medical device company that develops medical imaging tools for the diagnostic services. The company’s products include eyestar, DR-RACS, and neurotherm. Its eyestar product is a total eye disease screening program package, DR-RACS is an automated …
  • Saudi Electricity Co:発電所・企業SWOT分析
    Saudi Electricity Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Fitbit Inc.:戦略・SWOT・企業財務分析
    Fitbit Inc. - Strategy, SWOT and Corporate Finance Report Summary Fitbit Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ASM International NV (ASM):企業の財務・戦略的SWOT分析
    ASM International NV (ASM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Atomic Energy of Canada Ltd:企業の戦略的SWOT分析
    Atomic Energy of Canada Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆